Physician profile
Nora L Hsu
NPI 1073719449
$1,767.47
in general payments reported to CMS, 2019-2025
22 companies · $57.70 in 2025
The $57.70 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $235 · 2021: $251 · 2022: $579 · 2023: $271 · 2024: $125 · 2025: $57.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.72 | 2019-2023 | |
| Pfizer INC. | $219.91 | 2019-2023 | |
| Coopersurgical, INC. | $179.67 | 2020-2025 | Ally II Ups, Mara Console |
| Therapeuticsmd, INC. | $166.76 | 2019-2022 | |
| Exeltis, USA INC. | $150.46 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $143.59 | 2023-2024 | Veozah, Myrbetriq |
| Innovation Technologies INC | $119.26 | 2022-2023 | Irrisept |
| Aspira Women'S Health INC | $84.28 | 2022-2023 | Ova1 |
| Hologic Sales and Service, LLC | $65.03 | 2023 | Thinprep 2000 Processor, Aptima |
| Myovant Sciences INC. | $63.51 | 2022 | |
| Mayne Pharma Commercial LLC | $62.06 | 2021-2022 | |
| Baxter Healthcare | $39.27 | 2022-2025 | Perclot |
| Meditrina | $38.33 | 2022 | |
| Mylan Pharmaceuticals INC. | $38.19 | 2022 | |
| Ascend Therapeutics US, LLC | $36.36 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $31.03 | 2019-2020 | |
| Duchesnay USA Incorporated | $29.39 | 2019 | |
| Sage Therapeutics, LLC | $16.58 | 2022 | |
| Minerva Surgical, INC | $15.25 | 2021 | |
| Avion Pharmaceuticals | $13.91 | 2021 | |
| Organon LLC | $12.91 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nora Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.